InvestLog
← Back to Research← 返回研究
EWEarnings Release财报快讯SEC sourceSEC 来源Source link原始来源August 5, 20262026/8/5by InvestLog AIInvestLog AI 整理

Edwards Lifesciences Corporation (EW) 2026 Q2 financial resultsEdwards Lifesciences Corporation (EW) 2026 Q2 财报发布

Key Results

Edwards Lifesciences Corporation reported revenue $1.7B, net income $242M.

Profitability and Cash Flow

  • Period: 2026 Q2
  • Revenue: $1.7B
  • Gross profit: $1.3B; Gross margin: 77.5%
  • Net income: $242M; GAAP diluted EPS: $0.42
  • Operating cash flow: $696M; Capex: $132M; Free cash flow: $564M
  • Cash: $2.9B; Total debt: $704M; Net cash: $2.2B

    • Official release: 10-Q

    核心结果

    Edwards Lifesciences Corporation 公布2026 Q2财报：营收 $1.7B，净利润 $242M。

    财务指标

  • 期间：2026 Q2
  • 营收：$1.7B
  • 毛利润：$1.3B；毛利率：77.5%
  • 净利润：$242M；GAAP 稀释 EPS：$0.42
  • 经营现金流：$696M；资本开支：$132M；自由现金流：$564M
  • 现金：$2.9B；总债务：$704M；净现金：$2.2B
    • View EW stock details ->查看 EW 个股详情 ->

    This earnings research was prepared from company results, regulatory filings, and financial statements. It is for informational purposes only and does not constitute investment advice.这篇财报研究基于公司业绩公告、监管文件和财务报表整理。内容仅供参考，不构成投资建议。

    Related research相关阅读

    EW files 8-K — Item 7.01 Regulation FDEW · 8-K 披露

    8-K Event · May 4, 20268-K 披露 · 2026/5/4